Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ran Nussbaum currently holds 10,000 shares of Eloxx Pharmaceuticals, Inc. (ELOX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ran Nussbaum has been a net buyer of ELOX stock. They have purchased $40.0M and sold $28.6M worth of shares.
Ran Nussbaum's most recent insider trade was on Jun 3, 2026, when they sold 10,000 shares at $0.00 per share.
Ran Nussbaum serves as Executive at Eloxx Pharmaceuticals, Inc. (ELOX). They have executed 99 insider transactions totaling $68.7M over their tenure at the company.
Ran Nussbaum holds the position of Executive at Eloxx Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Ran Nussbaum has shown a buying trading pattern, with $40.0M in total purchases and $28.6M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ran Nussbaum was on Jan 16, 2020, when they sold $85.8M worth of ARQL shares. This transaction involved 4,290,550 shares at $20.00 per share.
Ran Nussbaum currently owns 10,000 shares of Eloxx Pharmaceuticals, Inc. (ELOX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ran Nussbaum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ran Nussbaum has 99 Form 4 filings on record as an insider at Eloxx Pharmaceuticals, Inc..
Set alerts for Ran Nussbaum and 40,000+ other insiders.